These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 28534431)

  • 1. Ameliorating effect of anti-Alzheimer's drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer's disease.
    Ahmed AS; Elgharabawy RM; Al-Najjar AH
    Exp Biol Med (Maywood); 2017 Jul; 242(13):1335-1344. PubMed ID: 28534431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined vildagliptin and memantine treatment downregulates expression of amyloid precursor protein, and total and phosphorylated tau in a rat model of combined Alzheimer's disease and type 2 diabetes.
    Khalaf SS; Hafez MM; Mehanna ET; Mesbah NM; Abo-Elmatty DM
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):685-695. PubMed ID: 30759264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antidiabetic agents on Alzheimer's disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin.
    Ali SK; Ali RH
    PLoS One; 2022; 17(7):e0271138. PubMed ID: 35802659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of plasma β-amyloid 40 and 42 concentration with type 2 diabetes among Chinese adults.
    Peng X; Xu Z; Mo X; Guo Q; Yin J; Xu M; Peng Z; Sun T; Zhou L; Peng X; Xu S; Yang W; Bao W; Shan Z; Li X; Liu L
    Diabetologia; 2020 May; 63(5):954-963. PubMed ID: 32034441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer's disease: possible mechanisms of IDE in T2D and AD.
    Li H; Wu J; Zhu L; Sha L; Yang S; Wei J; Ji L; Tang X; Mao K; Cao L; Wei N; Xie W; Yang Z
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29222348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
    Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
    J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Diabetes: a Therapeutic Strategy for Alzheimer's Disease?
    Ahn KC; Learman CR; Baker GB; Weaver CL; Chung PS; Kim HG; Song MS
    J Korean Med Sci; 2019 Dec; 34(46):e297. PubMed ID: 31779058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Hierro-Bujalance C; Ortegon E; Pickett E; Jackson R; Hernandez-Pacho F; Spires-Jones T; Garcia-Alloza M
    Mol Neurobiol; 2018 Jul; 55(7):6130-6144. PubMed ID: 29224179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Amyloid-β Peptides in Type 2 Diabetes: A Matched Case-Control Study.
    Peters KE; Davis WA; Taddei K; Martins RN; Masters CL; Davis TM; Bruce DG
    J Alzheimers Dis; 2017; 56(3):1127-1133. PubMed ID: 28106562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease.
    Ramos-Rodriguez JJ; Jimenez-Palomares M; Murillo-Carretero MI; Infante-Garcia C; Berrocoso E; Hernandez-Pacho F; Lechuga-Sancho AM; Cozar-Castellano I; Garcia-Alloza M
    Psychoneuroendocrinology; 2015 Dec; 62():69-79. PubMed ID: 26254770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition.
    Park JC; Han SH; Cho HJ; Byun MS; Yi D; Choe YM; Kang S; Jung ES; Won SJ; Kim EH; Kim YK; Lee DY; Mook-Jung I
    Alzheimers Res Ther; 2017 Mar; 9(1):20. PubMed ID: 28330509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Amnesic and Neuroprotective Effects of Fluoroethylnormemantine in a Pharmacological Mouse Model of Alzheimer's Disease.
    Couly S; Denus M; Bouchet M; Rubinstenn G; Maurice T
    Int J Neuropsychopharmacol; 2021 Feb; 24(2):142-157. PubMed ID: 32977336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraneuronal Amylin Deposition, Peroxidative Membrane Injury and Increased IL-1β Synthesis in Brains of Alzheimer's Disease Patients with Type-2 Diabetes and in Diabetic HIP Rats.
    Verma N; Ly H; Liu M; Chen J; Zhu H; Chow M; Hersh LB; Despa F
    J Alzheimers Dis; 2016 May; 53(1):259-72. PubMed ID: 27163815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Galindo-Gonzalez L; Garcia-Alloza M
    Psychoneuroendocrinology; 2016 Mar; 65():15-25. PubMed ID: 26708068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain.
    Henderson BW; Gentry EG; Rush T; Troncoso JC; Thambisetty M; Montine TJ; Herskowitz JH
    J Neurochem; 2016 Aug; 138(4):525-31. PubMed ID: 27246255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent folic acid and memantine treatments promote synergistic or additive protection against Aβ(25-35) peptide-induced apoptosis in SH-SY5Y cells mediated by mitochondria stress-associated death signals.
    Chen TF; Tang MC; Chou CH; Chiu MJ; Huang RF
    Food Chem Toxicol; 2013 Dec; 62():538-47. PubMed ID: 24055771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DPP-4 Inhibitor Linagliptin Attenuates Aβ-induced Cytotoxicity through Activation of AMPK in Neuronal Cells.
    Kornelius E; Lin CL; Chang HH; Li HH; Huang WN; Yang YS; Lu YL; Peng CH; Huang CN
    CNS Neurosci Ther; 2015 Jul; 21(7):549-57. PubMed ID: 26010513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.